|

Odetiglucan Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 2: 2

Top Sponsors

  • University of Pennsylvania1
  • Abramson Cancer Center at Penn Medicine1

Indications

  • Liver Disease1
  • Colorectal Adenocarcinoma Metastatic in the Liver1
  • Pancreatic Ductal Adenocarcinoma1
  • Cancer1

Philadelphia, Pennsylvania2 trials

Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Cancer

Hospital of the University of Pennsylvania

Phase 2
Pembrolizumab and Odetiglucan in Liver Predominant Metastatic Colorectal Adenocarcinoma

Abramson Cancer Center at the University of Pennsylvania

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.